TARS

Bobak R. Azamian

Known title: President/CEO and Board ChairCIK: 0001827672

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 12, 2026

Tarsus Reports XDEMVY Revenue and Option‑Style Retina Deals. The article notes that Tarsus’s drug XDEMVY is now generating revenue to cover operating costs. It also explains that the company’s retina product deals are structured like options, potentially providing flexible upside. These developments may improve the company’s cash flow outlook and support future growth initiatives.

this person other insiders at TARS

Transaction History

TARS▼ Sell$801K
TARS▼ Sell$335K
TARS▼ Sell$281K
TARS▼ Sell$802K
TARS▼ Sell$802K
TARS▼ Sell$762K
TARS▲ Buy—
TARS▼ Sell$449K
TARS▼ Sell$47K
TARS▼ Sell$0
TARS▼ Sell$332K
TARS▼ Sell$300K
TARS▼ Sell$300K
TARS▼ Sell$428K
TARS▼ Sell$405K
TARS▼ Sell$330K
TARS▲ Buy—
TARS▼ Sell$319K
TARS▲ Buy—
TARS▼ Sell$162K
TARS▼ Sell$188K
TARS▼ Sell$622K
TARS▼ Sell$52K
TARS▼ Sell$91K
TARS▼ Sell$4K
TARS▼ Sell$106K
TARS▼ Sell$138K
TARS▼ Sell$138K
TARS▼ Sell$80K
TARS▼ Sell$2.0M
TARS▼ Sell$156K
TARS▼ Sell$149K
TARS▼ Sell$167K
TARS▼ Sell$62K
TARS▼ Sell$127K
TARS▼ Sell$151K
TARS▼ Sell$88K
TARS▼ Sell$65K
TARS▼ Sell$35K
TARS▼ Sell$109K
TARS▼ Sell$9K
TARS▼ Sell$9K
TARS▼ Sell$9K
TARS▼ Sell$9K
TARS▼ Sell$11K
TARS▼ Sell$11K
TARS▲ Buy—
TARS▼ Sell$110K
TARS▼ Sell$11K
TARS▼ Sell$73K
TARS▼ Sell$122K
TARS▼ Sell$136K
TARS▼ Sell$75K
TARS▼ Sell$4K
TARS▼ Sell$116K
TARS▼ Sell$59K
TARS▼ Sell$14K
TARS▼ Sell$11K
TARS▼ Sell$6K
TARS▼ Sell$117K
TARS▼ Sell$8K
TARS▼ Sell$97K
TARS▼ Sell$122K
TARS▼ Sell$13K
TARS▼ Sell$161K
TARS▼ Sell$134K
TARS▼ Sell$2K
TARS▼ Sell$97K
TARS▼ Sell$46K
TARS▼ Sell$129K
TARS▼ Sell$2K
TARS▼ Sell$144K
TARS▼ Sell$120K
TARS▼ Sell$13K
TARS▼ Sell$57K
TARS▼ Sell$52K
TARS▼ Sell$20K
TARS▼ Sell$15K
TARS▼ Sell$140K
TARS▼ Sell$23K
TARS▼ Sell$21K
TARS▼ Sell$124K
TARS▼ Sell$8K
TARS▼ Sell$145K
TARS▼ Sell$3K

We use analytics to understand how market-wall is used. No personal data is sold.